Paul F. Lizzul, Chief Medical Officer at ANAPTYSBIO, INC (ANAB), sold 2,105 shares at $19.48 ($41K) on 2023-09-14, disclosed to the SEC on 2023-09-18.
Open-market sale of $41k ANAB by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANAB | SELL | 2026-01-06 | $183K | — | Filing → |
| ANAB | SELL | 2025-12-23 | $75K | — | Filing → |
| ANAB | SELL | 2024-09-24 | $58K | — | Filing → |